Aramis Pharmaceuticals is a US based healthcare company with rights, and access to rights, for healthcare products that are ready to be commercialized, or are in the final stage of development for the North American market.
Aramis licensees these products strategically in operational North American healthcare or consumer companies in exchange for an equity position in those companies, or for cash as a second option.
Aramis is also the marketing liaison between the owner of the product and the commercial partner.